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ABSTRACT
Mehta, Trupthi. M.S., Biochemistry and Molecular Biology, Wright State University,
2018. Availability of Fermentable Nutrients Affects Gut Microbiota Composition.
Recent studies have increasingly established the role of gut microbiota in human
health and disease. Diseases such as inflammatory bowel disease, colon cancer,
cardiovascular disease and many neurological disorders have been linked to specific gut
microbiota composition and disturbances. There have also been attempts in recent years
to modulate gut microbial composition with the use of prebiotics and probiotics to
promote healthy gut and prevent diseases. This thesis investigates whether the availability
of fermentable nutrients high in fiber and antioxidants such as found in green coffee,
roasted coffee, and salami infused with various prebiotics altered the composition and
abundance of gut microbiota. A significant difference in the composition of microbial
genera was found among samples containing fermentable nutrients compared to control.
Our study also showed there is a difference in abundance of Bifidobacterium, Bacteroides
and Dorea, which were the top 3 most abundant genera among salami samples. Also,
there was a difference in abundance of Escherichia/Shigella, Bacteroides and
Bifidobacterium, which were the top 3 abundant genera among the coffee samples.
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1. Introduction
Gut microbiota
When Robert Koch published his four postulates supporting the germ
theory of disease, microbes were generally viewed as agents of harm. However, microbes
play a larger role in human biology than just causing disease. This larger role is
exemplified by the human gut microbiome, where commensal microorganisms depend on
energy sources ingested by the host and produce metabolites that can affect the human
immune system, nervous system, and metabolism (Zhang et al., 2015). Whether these
commensal organisms benefit or harm the host can sometimes depend on its composition
that is influenced by the host’s diet. For instance, a protein- rich diet favors bacteria that
produce ammonia, hydrogen sulfide, and certain amines which may cause a condition
called leaky gut. Leaky gut causes inflammation that may lead to cancer and
inflammatory bowel disease (IBD) (Marcheshi et al., 2016).
Colonization of the gut by microbes occurs as early as birth. Colonization of the
infant gut occurs by exposure to the birth canal’s own microbial flora. Therefore, the
mode of delivery plays a role in the composition of an infant’s microbiome. For instance,
infants delivered vaginally have a different composition of gut microbiome when
compared to infants delivered via caesarian section (Bello et al., 2010). However, the gut
microbiome is not stagnant as infants grow, but in fact changes significantly over a
lifetime (Bello et al., 2010).
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One factor that plays a major role in the composition of the gut microbiome is
diet. For example, adolescents in Egypt have different microbial composition when
compared to adolescents in the United States because of the diet; Western diet being high
in animal proteins, and fats contributes to a different microbial composition and diversity
compared to Mediterranean diet in Egypt which is high in fruits, vegetables, fiber, plant
protein, and fats (Shankar et al., 2017). Although a causal link between the composition
of the gut microbiome and specific human diseases has yet to be established, there is
burgeoning body of evidence that this link might exist. For example, a study by (Matilla
et al., 2012) followed 70 C. difficle infected patients who received fecal transplantation
(resistant to other treatments) for a year and the analysis showed that 66 of 70 patients
(94%) recovered. This exemplifies the therapeutic role of altering gut microbial
composition to promote health. Knowing that gut microbiota can play a role in human
health and disease, modulation of gut microbiota becomes one of the ways to treat and
prevent diseases. Besides establishing causal relationships between microbes, human
health and disease, it is imperative to conduct more research on modulation of gut
microbiota.

Human microbiome project (HMP)
In 2007, National Institutes of Health initiated the human microbiome project to
characterize the microbiome in the human body and understand its significance. The
project was aimed to understand the different microbial ecosystems in different sites of
the body. It also aimed to further understand the function of microbiome in human health
and disease. The project also developed tools and technology needed to characterize the
human microbiome while making it available to the other researchers. One of the insights
2

borne out of this project was that the human microbiome is dynamic and personalized.
Human microbiome diversity and abundance differs from one person to another and
changes with time depending on the diet, environment and health status (Costella et al.,
2009). However, different compositions of microbial ecosystems or network may have
similar function. Yet another conclusion is that variability in microbial diversity and
richness exist among different sites of the body. That is different sites exhibit different
within sample diversity of microbial species and abundance. They also concluded that gut
is the site where there is greatest abundance of microbes found within the human body.

Role of gut microbiota in health and disease
Human gut microbiota mainly consists of strict anaerobes and some facultative
anaerobes. Most dominant phyla include Bacteroidetes and Firmicutes (Johnson et al.,
2016). However, the species variability within these phyla and their respective abundance
is highly personalized among individuals. In health, these variable species of bacteria in
the gut share similar functionality such as prevent the overgrowth of pathogenic bacteria
and partially maintain pH by production of short chain fatty acids (SCFA) such as
butyrate, acetate and propionate (Lynch et al., 2016). They also aid in the maturation of
the immune system, digest substrates that are otherwise indigestible by human gut,
produce neurotransmitters such as GABA and serotonin that are important for regulating
nervous system and the GI system, synthesize vitamins, and provide energy (Lynch et al.,
2016).
Dysbiosis of the human gut microbiota is linked to many diseases. For example,
obesity is a major health concern in the western world. Although obesity like many other
diseases is a result of complex processes, one of its hallmarks as it pertains to the gut
3

microbiome is greater abundance of Firmicutes compared to Bacteroidetes which is
reversed in non- obese individuals (Clemente et al., 2012). Also, changes in abundance of
gut microbiota are observed in Type 1 diabetes; there is a decreased diversity of bacteria
with greater abundance of Bacteroides ovatus and Firmicutes strain CO19 (Giongo et al.,
2011). Further, multiple sclerosis phenotype can be seen in germ free mice when they are
transplanted with specific microbial taxa in the gut (Lee and Mazmanian et al., 2011). On
the other hand, introduction of Bacteroides fragilis seem to protect the host multiple
sclerosis (Lee and Mazmanian et al., 2011).
Colorectal cancer is a leading cause of cancer death, and some microbes are
suspected to play a role in its invasiveness and its response to chemotherapy. Some of the
players suspected to be are Streptococcus bovis, Escherichia coli, Enterococcus faecalis,
Bacteroides fragilis, Clostridium septicum and Fusobacterium (Gagniere et al., 2016).
However, the exact mechanism by which these microbes promote carcinogenesis is not
well understood at this point. One theory is that microbial microenvironment in colon
may activate certain immune pathways that promote carcinogenesis (Gagniere et al.,
2016). We are also not sure whether these microbial changes are a cause or consequence
of the colorectal cancer (Gagniere et al., 2016). Further studies have found reduction in
the Clostridiales bacteria which produce butyrate (which can serve as an antiinflammatory agent) in people with type 2 diabetes. Studies have related changes in gut
microbiota to type 2 diabetes through the development of low grade inflammation in the
gut (Indias et al., 2014).
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Human nutrition and gut microbiota
As mentioned earlier, diet plays a major role in the composition of gut microbiota.
Different microbes are associated with different types of diet not just in abundance but
also in type. Different microbes also enhance or inhibit different physiological states in
the human body. Western diet being high in animal proteins results in increased
abundance of Alistipes, Bilophila, Bacteroides, Ruminococcus and decreased
Bifidobacterium (Singh et al., 2017). As a consequence of the changes caused by the
western diet, there is increased trimethylamine N- oxide (TMAO) and decreased short
chain fatty acids (SCFA) elevating the risk of cardiovascular disease (CVD) and
inflammatory bowel disease (IBD) (Singh et al., 2017). On the other hand, a
Mediterranean diet consisting of dietary fiber, polyphenols from vegetables and fruits,
and unsaturated fat favors growth and relative abundance of Bifidobacterium and
Lactobacillus, while simultaneously decreasing Bacteroides and Clostridium perfringes.
This results in increased production of SCFAs leading to decreased inflammation,
increased gut barrier between intestinal epithelial cells and higher number of regulatory T
cells (Singh et al., 2017). Intake of high levels of saturated fat causes an increase in
Bacteroides, Bilophila and Faecalibacterium, which is associated with decreased insulin
sensitivity and increased Toll- like receptor (TLR) activation and WAT (White Adipose
Tissue) inflammation (Singh et al., 2017). These changes may further lead to increased
cholesterol and low-density lipoproteins (LDL) levels in the body (Singh et al.,) which
may increase the risk of cardiovascular disease. On the other hand, increased intake of
unsaturated fats is linked to increase in Sterptococcus, Lactobacillus, Bifidobacteria and
Akkermansia muciniphila which has the opposite effect, leading to decreased total
5

cholesterol and LDL levels (Singh et al., 2017). Carbohydrates, polyphenols and dietary
fiber also influence gut microbiota to a great extent. Dietary fiber and polyphenols seem
to increase Lactobacillus and Bifidobacteria while decreasing Clostridium (pathogenic)
and Bacteroides (Singh et al., 2017).

Modulating gut microbial network
There are several methods by which the gut microbial composition and diversity
can be modulated to promote health, which include probiotic, prebiotics, fecal
transplantation, and diet (Walsh et al., 2014). As defined by World Health Organization,
probiotics are live organisms that when ingested confer benefits to the host. They are
used in supplements and found in foods such as yogurt, which when ingested can
colonize human gastrointestinal tract. Lactobacillus and Bifidobacterium genera are the
most commonly used as probiotics in food and supplements. They confer benefits by
interfering with the colonization and growth of pathogenic bacteria, reducing local
inflammation and LDL cholesterol levels (Walsh et al., 2014). Besides probiotics,
ingested food can be supplemented with prebiotics to manipulate the gut microbial
composition. Prebiotics are non-digestible nutrients by human enzymes, such as inulin
that can be ingested to promote the growth of healthy bacteria such as Lactobacillus and
Bifidobacterium that benefit the organism (Yasmin et al., 2015).
In addition, one can treat Clostridium difficile infection caused by its over-growth
and loss of microbial diversity due to the use of widespread antibiotics with fecal
transplantation. Fecal transplantation has been successfully used to treat Clostridium
difficile infection and restore microbial balance to the infected person’s gut in almost
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80% of the cases regardless of the mode of delivery (that is via oral FMT capsules, FMT
enemas or FMT duodenal infusions) (Gianotti et al., 2017).
One can also manipulate gut microbiota to confer health benefits by switching
from Western diet high in animal protein and fats to vegan or vegetarian diet high in
dietary fiber and polyphenols that induces colonization of bacteria that promote health
and increase microbial gene richness. For example, a significant increase in the
Bacteroidetes to Firmicutes ratio, a microbial profile associated with lean individuals
(Walsh et al., 2014).

Studying human microbiota - Brief overview
Gut microbiota is hard to grow in a culture. In the past, very few strains of
bacteria from a fecal sample would grow in culture so it was hard to characterize it. Now,
with the growing number of technologies such as high-throughput sequencing, it has
become possible to identify the different types of bacteria present in a sample and its
abundance without culturing the fecal sample, but by amplifying variable gene regions of
16S RNA gene. Today, we can also characterize the type of metabolites produced by the
bacteria by NMR spectroscopy or mass spectrometry and the functions of a microbial
community, and not just its structure.
We can begin to study a microbial community in an environmental sample by
collecting a sample such as fecal samples. Genomic DNA then can be extracted, and
variable regions of 16S RNA marker gene that specify the identity of microbes in a
community can be amplified (Goodrich et al., 2014). Following that, amplicons are
sequenced with high- throughput sequencing and further analyzed through available
software like Qiime. Qiime processes sequences and bins them into different OTUs
7

(Operational Taxonomic Unit), corresponding to roughly species level classification.
Binned OTUs are classified for taxonomy through a Ribosomal Database Project (RDP)
classifier (Goodrich et al., 2014) and further number of OTUs present in each sample and
the genus it belongs to can be calculated by multiple steps using excel. One can also
calculate the differences and microbial diversity between samples (beta diversity) and
visualize it through the application of Principal Coordinate Analysis (PCoA) or Principal
Component Analysis (PCA) (Goodrich et al., 2014). In addition, if there are two or more
known groups of samples or clusters of samples then one can understand what variables
are driving those differences between groups by using another algorithm called
Orthogonal Projection to Latent Structures - Discriminate Analysis (OPLS-DA).

Thesis overview
This study consisted of characterizing the gut microbial community and finding
the differences in microbial composition between human fecal samples, when they are
mixed and incubated with various fermentable nutrients such as antioxidants (green and
roasted coffee), prebiotics (inulin and fiber) and probiotic (Lactobacillus bacteria)
supplemented in food of choice such as salami or coffee. Our goal was to determine if
ingesting fermentable nutrients with food and beverage (coffee) can modulate the gut
microbial community in its structure, richness and diversity. We processed and analyzed
the fermented human fecal mixture samples of green coffee and roasted coffee from
Vietnam, Brazil and Argentina. We also processed and analyzed mixture of salami,
probiotics and prebiotics that underwent fermentation, in vitro digestion and again mixed
with human fecal samples. We extracted genomic DNA (gDNA), amplified variable
regions V1V2 and V4 of the 16s ribosomal RNA (rRNA) gene, and sequenced the
8

amplicons through high-throughput sequencing. This was followed by binning of
sequences into OTUs, classifying them and analyzing the community structure. We
characterized the genera of microbes present in samples, calculate abundances of genera,
beta diversity, and alpha diversity and find out if there are differences in microbial
community structure between samples that underwent different treatments.

9

2. Materials & Methods
In vitro digestion and fermentation of green and roasted coffee
Green coffee and roasted coffee samples (imported from Columbia, Vietnam and
Brazil) were obtained from a coffee shop in Granada, Spain. Further processing involving
the in vitro digestion and fermentation of coffee samples was carried out by our
collaborators at the University of Granada, Spain. Coffee samples were first ground in a
coffee mill. Following that, 40 g of coffee grounds of each sample were brewed with 500
mL of distilled water using a mocha coffee maker. Aliquots of brewed coffee samples
were prepared for in vitro digestion-fermentation.
Brewed coffee samples went through in vitro digestion followed by fermentation
such that it mimicked the physiological process of the human gastrointestinal system. The
protocol used is described briefly as follows; in the oral phase 5 mL of SSF (simulated
salivary fluid) with alpha-amylase (150 U/mL) and 25 µL of CaCl2 were added to 5 mL
of coffee brew and the mixture was incubated at 37ºC for 2 minutes. Then, 10 mL of SGF
(simulated gastric fluid) with pepsin (4000 U/mL) and 5 µL of CaCl2 were added and the
pH was lowered to 3.0 by adding 1N HCl; the mixture was then incubated at 37ºC for 2
hours. Finally, 20 mL of SIF (simulated intestinal fluid) with pancreatin (26.74 mg/mL),
bile salts (20mM) and 40 µL of CaCl2 were added and the pH was raised to 7.0 with 1N
NaOH, after which the mixture was incubated at 37ºC for 2 hours. The enzymatic
reactions were brought to a halt by immersing the tubes in iced water. The samples were
10

then centrifuged at 6000 rpm for 10 minutes at 4oC and the supernatants were stored at 80oC until further analysis. 10% of the supernatant was added to the solid residue in order
to mimic the fraction that is not readily absorbed after digestion. Then, the mixed
fractions were frozen for further freeze-drying (Perez-Burillo et al., 2018).
Next, the samples were subjected to in vitro fermentation. Fecal samples from
three healthy donors (donors not taking antibiotics with a mean Body Mass Index of
21.3) were collected in the morning, placed in sterile containers and stored at 4oC until
the inoculum was prepared. 500 mg of digested freeze-dried residue was placed in a
screw-cap tube. Then, 10% of the digestion supernatant was added in proportion to the
digested residue to be fermented, as 10% of the theoretical absorbable fraction goes to the
large intestine. Next, 7.5 mL of fermentation medium (1L of peptone water (15 g/L), 50
mL of reductive solution (312 mg of cysteine and 312 mg of sodium sulphide in 48 mL
of water and 2 mL of NaOH 1M), and 1.25 mL of resazurin (0.1% w/v)) and 2 mL of
inoculum (consisting of a solution of 32% feces in 100 mM phosphate buffer, (pH 7.0)
were added, to reach a final volume of 10 mL plus supernatant volume. Nitrogen was
bubbled through the mixture to produce an anaerobic atmosphere and the mixture was
then incubated at 37ºC for 20 hours under agitation. After fermentation the samples were
immersed in ice to stop the microbial activity and centrifuged at 6000 rpm for ten
minutes. The supernatant was collected as a soluble fraction that would be potentially
absorbed after fermentation in the gastrointestinal tract and stored at -80ºC. The solid
residue representing the non-absorbed fraction after fermentation was also stored in order
to characterize the microbial community profiles (Perez-Burillo et al.,2018).
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In vitro digestion and fermentation of salami samples supplemented
with prebiotics
Salami was obtained from a local meat company in Granada, Spain. Salami was
minced and each individual sample of minced salami was mixed with a different type of
prebiotic. For example, one sample contained minced salami with inulin, and the another
one with fiber gum. To some samples, a probiotic named L. rhamnosus was also added
along with the prebiotic. Each prepared sample were subjected to similar in vitro
digestion-fermentation procedure as described above for coffee samples (Figure 2.1)

Figure 2.1: summary of the mixtures used to mimic the physiologic process of
digestion in the gastrointestinal system for the salami samples. (Courtesy of Sergio Perez
Burillo).
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The digested salami mixture was mixed with fecal samples from three different
people, followed by fermentation in an incubator for 20 hours in an anaerobic
atmosphere. After fermentation the samples were immersed in ice to stop the microbial
activity and centrifuged at 6000 rpm for ten minutes. The supernatant was collected as a
soluble fraction potentially absorbed after fermentation and stored at -80ºC. The solid
residue representing the non-absorbed fraction after fermentation was also stored in order
to characterize the microbial community profiles (Perez-Burillo et al., 2018). The
digestion-fermentation was performed by our collaborators at University of Granada,
Spain.
Table 2.1: Sample information for the coffee fermentation.
Sample content

OP
Sample
ID

Sequenced
regions

Type of coffee
Green/Roasted

Arabica coffee from
Brazil (Moka)
Arabica roasted coffee
from Brazil (Moka)
Arabica roasted coffee
from Vietnam (Moka)
Arabica coffee from
Vietnam (Moka)
Arabica coffee from
Columbia (Moka)
Arabica roasted coffee
from Columbia (Moka)

fCOF01

V4

Green

fCOF02

V4

Roasted

fCOF03

V4

Roasted

fCOF04

V4

Green

fCOF05

V4

Green

fCOF06

V4

Roasted

13

Table 2.2: Sample information for the salami fermentation.
Sample content

Sequenced regions

Salami control

V1V2 + V4

Fermentation fluid blank

V1V2 + V4

Salami + Lactobacillus rhamnosus + inulin

V1V2 + V4

Salami + Lactobacillus rhamnosus + fibergum

V1V2 + V4

Salami + Lactobacillus rhamnosus + citric fiber

V1V2 + V4

Salami + Lactobacillus rhamnosus + citric fiber + herbal extract V1V2 + V4

Genomic DNA extraction
The in vitro digested-fermented samples of the coffee and salami received from Spain
were further processed and analyzed to profile the microbial community present in the
samples. Genomic DNA (g DNA) was extracted using ZR Fecal DNA MiniPrep kit
(ZYMO Research). The protocol is as follows:
1. 750 ul of lysis solution was added to the tube containing the sample. The sample was
mixed with the lysis solution before transferring to the ZR Bashing-Bead Lysis Tube.
2. The BashingBead Lysis tube containing the sample and the lysis solution was
secured and processed with a Disruptor Genie at maximum speed for 5 minutes.
3. The BashingBead lysis tube was centrifuged at 10,000 x g for one minute.
4. 400 ul of the supernatant was transferred to a Zymo-Spin IV Spin Filter in a
Collection Tube and centrifuged at 7,000 rpm for 1 minute.
5. 1,200 ul of Fecal DNA Binding Buffer was added to the filtrate in the Collection
Tube from Step 4.
14

6. 800 ul of the mixture from Step 5 was transferred to a Zymo-Spin IIC Column in a
Collection tube and was centrifuged at 10,000 x g for 1 minute.
7. The flow from the collection tube was discarded and Step 6 was repeated.
8. 200 ul DNA Pre-Wash Buffer was added to the Zymo-Spin IIC Column in a new
collection tube and centrifuged at 10,000 x g for 1 minute
9. 500 ul of Fecal DNA Wash Buffer was added to the Zymo-Spin IIC Column and
centrifuged at 10,000 x g for 1 minute.
10. Zymo-Spin IIC Column was transferred to a clean 1.5 ml micro centrifuge tube and
32 ul microliter of warm elution buffer (heated to 50º Celsius) was added. It was then
left to sit for 2 minutes.
11. Zymo-Spin IIC Column with the elution buffer + the micro centrifuge tube was
centrifuged at 10,000 x g for 1 minute.
12. A sample eluted of gDNA was run through Electrophoresis gel to check the presence
and quality of the DNA.
13. The eluted DNA in the micro-centrifuge tube was stored at -20º Celsius until further
processing.

Amplification and purification of variable regions 1 - 2 (V1V2) and 4
(V4) of 16S RNA gene
In order to increase the sensitivity of high-throughput sequencing, variable
regions of 16S ribosomal RNA gene were amplified. PCR reaction was run for each
sample with 25 ng of extracted gDNA. Genomic DNA for salami samples was amplified
using two pairs of primers, one targeting 16S rDNA V1-V2 region [forward primer 5’AGRGTTYGATYMTGGCTCAG-3’ and reverse primer 5’15

GCWGCCWCCCGTAGGWGT-3’], and another targeting V4 region [forward primer 5’GCCAGCMGCCGCGG-3’ and reverse primer 5’- GGACTACHVGGGTWTCTAAT3’]. Genomic DNA of coffee samples was amplified using one pair of primers targeting
only V4 region [forward primer 5’- GCCAGCMGCCGCGG-3’ and reverse primer 5’GGACTACHVGGGTWTCTAAT-3’]. PCR amplification included 10 cycles of linear
PCR with forward primer alone. Then, 25 cycles of traditional exponential PCR with
reverse primer added. Inclusion of the 10 cycles of linear PCR decreases the stochasticity
of the first few PCR reaction steps.
Amplicons were purified with 27.5 ul of Ampure bead solution. Following the
purification, purified dsDNA concentration was measured using a Qubit spectrometer in
the lab. Sample quality was measured by agarose gel electrophoresis. Purified DNA
samples were stored at -20ºC until high-throughput sequencing.
Table 2.3: The contents of the PCR reaction used to amplify the variable regions of
16sRNA gene for each sample.
25 ng of gDNA
12.5 ul of 2x MasterMix
2 ul of Forward Fusion Primer (barcoded, Ion torrent P1 adaptor sequence included and
variable region specific)
2 ul of Reverse Fusion Primer (variable region specific)
X ul DNAse/RNAse free water (adjusted based on the volume of gDNA added, such that
the final volume of the reaction is 25 ul)
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Table 2.4: Thermocycler conditions used for amplification of 16s rDNA variable
regions.

Step 1 95ºC for 2 minutes
Step 2 95ºC for 30 seconds
Step 3 55ºC for 30 seconds
Step 4 72ºC for 1 minute 30 seconds
Step 5 Go to step 2: Cycles - 9+30
Step 6 72ºC for 10 minutes

High-throughput sequencing
We used the Ion Torrent Sequencing technology to sequence the prepared
template DNA following the PCR amplification. Ion Torrent PGM (personal genome
machine) used utilizes the hydrogen ion detection- based sequencing technology. It
sequences by releasing of hydrogen ions while adding nucleotides to the growing strand.
Hydrogen ions released is sensed by a transistor which converts the chemical signal into a
voltage signal that is recorded. This reaction takes place in parallel in many micro wells
containing micro beads with primed template DNA sequences. Micro wells are exposed
to dATP, dGTP, dCTP, and dTTP nucleotides alternatively. With each round of
nucleotide exposure, micro wells incorporating the nucleotide and thus, producing
hydrogen ions are converted into a voltage signal. The voltage signal produced is
recorded for each micro well which then get translated into a sequence of letters G, C, A,
or T depending on the nucleotide used for the reaction (Merriman et al., 2012). These
sequence reads for each micro well are transferred to a file compatible for further
processing through software such as Qiime.
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Experimentally, purified amplicons were pooled in equimolar concentration and
sequencing libraries were further prepared through emulsion PCR with Ion PGM
Template OT2 400 kit (Life Technologies, Inc.) following the manufacturer’s protocol.
High- throughput sequencing was carried out on Ion Torrent PGM using Ion PGM
sequencing 400 kit and Ion 316 chip. We obtained an average of 16,954 sequence reads
per sample for the coffee samples and an average of 12,889 sequence reads per sample
for the salami samples.

Downstream processing
Qiime is a linux based bioinformatics software available to process the sequence
data obtained by high throughput sequencing. It can be used to produce a refined OTU
matrix table with taxonomy which can be further processed using excel templates to
characterize the microbial community in terms of species/genus identity, abundance and
diversity.
The sequences obtained were trimmed and assigned to their respective samples
(demultiplexing). Then, the trimmed and demultiplexed sequences were subjected to
Operational Taxonomic Unit (OTU) picking through the open reference method; this
process refers to an established database and clusters the sequences of each sample into
an abstract bin labeled with OTU (roughly corresponds to species level identification).
Sequences belonging to each OTU bin meet the 97% similarity threshold to the reference
sequence of the database. Through the open reference method of OTU picking, sequences
that do not have an established reference are binned into a new OTU bin and assigned a
new representative sequence. This prevents the loss of reads.
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The OTU read counts tables created by Microsoft Qiime after OTU picking was
subjected to 16S rRNA gene copy number adjustment by using Excel. In the process of
copy number adjustment, an accurate number of read counts per organism are calculated
by taking the total read counts for each OTU corresponding to each organism and
dividing it by a predicted number of 16S rRNA gene copies per organism.
In addition, it is possible to assign taxonomy for each OTU using the
representative sequence file generated during the OTU picking step. The file is run
through an online source of RDP classifier and the output file obtained is further
processed with 16S copy number adjusted excel file generating a final 16S copy number
adjusted OTU table with taxonomy. Further, the new table with the derived cell counts
was rarefied to the lowest total number read counts among the samples in Qiime.
Rarefaction is done to obtain an accurate number of species diversity per sample without
the mere presence of higher number of organisms per sample confounding the value of
species diversity (Nipperess et al., 2013). The rarefied table is then used to create a
cumulative file (using an excel template), containing information on abundance counts of
genera and phyla for each sample.
Figure 2.2 summarizes the steps involved in downstream processing of sequences
of the salami and the coffee project. All steps shown are common to both projects except
for Orthogonal Projection to Latent Structures which was done to find the discriminating
genera between the two groups, roasted coffee and green coffee of the coffee project.
Further, the rarefied OTU table was used to create a Principal Coordinate
Analysis (PCoA) plot. PCoA is a method used to calculate and visualize dissimilarities
among samples. It does so by creating a dissimilarity (distance) matrix based on the ratio
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of branch length leading to the microbial taxa of the phylogenetic tree to the sum of all
branch lengths present in the community. Data of dissimilarity matrix can be transformed
into PCoA plots, to depict the dissimilarity among the samples on two coordinate axes
with most variance in variables (species, genus or metabolites) (Ramette 2007).

Pre-processing
• Extract read sequences
• Trim barcodes and primer
• Remove chimeras and low quality reads
• Demultiplexing

OTU Picking
• OTU picking through open reference
Taxonomy Identification & 16SrRNA gene
copy adjustment
• Taxonomy identification through an online
RDP classifier
• 16S rRNA gene copy adjustment and
rarefaction
Diversity Analysis
• Beta diversity through UniFrac distance
matrix
• Alpha diversity through Shannon Index,
Simpson Index
Data Analysis & Visualization
• Principal Coordinate Analysis (PCoA)
• Orthogonal Projections to Latent Structrures
(OPLS-DA)

Figure 2.2: Steps involved in analysis of data obtained after high-throughput
sequencing
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Similar PCoA plots can be produced for the genus level data. We used the OTU
level information and picked OTU representatives to assign to genera for samples using
an excel template. For the salami samples, sequence information of both V1V2 and V4
regions of samples were combined and then final identification of species was obtained.
Again, a representative species for each OTU was picked for the assignment of genera in
their respective samples.
In addition to PCoA, a discriminant analysis was run on two groups of samples
belonging to the coffee samples (roasted coffee and green coffee). Orthogonal Projections
to Latent Structure - Discriminating Analysis (OPLS - DA) was used describe the hidden
(latent) variables, in our case genera that discriminated the two classes (roasted coffee
and green coffee). We performed OPLS-DA using R Studio on the genus level abundance
dataset. A table for describing the top discriminating genera was created for each group.
Beta diversity was calculated through UniFrac phylogenetic distance dissimilarity
matrix, while alpha diversity (within sample microbial diversity) was calculated using the
Simpson Index and Shannon Index indices as described below.
Simpson Index:
pi – Fraction of individuals of the species i.
S – Number of species.
Range: 0 – 1; 0 – Infinite diversity; 1 – No diversity.
Shannon Index:
pi – Fraction of individuals of the species i.
S – Number of species.
Range: 0 - ∞; 0 – No diversity; ∞ – Infinite diversity.
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3. Results
Coffee project results
Number of sequences obtained after high- throughput sequencing of amplicons
for each coffee samples is described (table 3.1).
Table 3.1: High-throughput sequencing reads of the coffee sample
Sample Content
fCOF01 Arabica coffee from Brazil (Moka)

V4 reads
13825

fCOF02 Arabica roasted coffee from Brazil (Moka)

17866

fCOF03 Arabica roasted coffee from Vietnam (Moka)

18358

fCOF04 Arabica coffee from Vietnam (Moka)

19135

fCOF05 Arabica coffee from Columbis (Moka)

13253

fCOF06 Arabica roasted coffee from Columbia (Moka) 19287

Relative genus level abundance
The abundance of each genus present in each sample was calculated using a
custom Microsoft Excel template. Figure 3.1 shows the top 9 abundant genera in each
sample.
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100%
90%

Escherichia/Shigella

80%

Bifidobacterium

70%

Bacteroides
Other

60%

Blautia

50%

Ruminococcus

40%

Roseburia

30%

Parabacteroides

20%

Lachnospiracea IS

10%

Dorea

0%
fCOF01

fCOF04

fCOF05

Green Coffee

fCOF02

fCOF03

fCOF06

Roasted Coffee

Figure 3.1 Top nine genera among the samples of the coffee project on a linear scale.
Escherichia/Shigella and Bifidobacterium constitute the top 2 genera in abundance.
These genera are present in every sample; however, the amount of each genus in each
sample differs slightly. The difference in abundances of genera may explain the varying
degrees of microbial dynamics in terms of metabolites, and colonization of microbes in
each sample.
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PCoA of genus abundance dataset
PCoA was run in Qiime using a script to visualize the dissimilarity between
samples. PCoA takes the dissimilarity matrix and projects the samples on the first axis of
highest variability, then on the second most and so on. PCoA informs us if there is any
difference among samples in terms of microbial composition. Figure 3.2 below represents
the weighted phylogenetic distance UniFrac based plot of PCoA done on the genus level
inputs of V4 region.
2

1
0
PC2

-4

-2

0

2

4

-1
-2

-3

Green Coffee

-4
PC1

Roasted Coffee

Figure 3.2: Weighted PCoA plot demonstrating separation between coffee samples.
PC1 represents the dimension representing the variable where the most variability was
found among samples. PC2 is the second most variable dimension. PCoA shows a clear
separation between samples of green coffee and roasted coffee. Thus, indicating that
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different types of coffee treatments are correlated with different microbial community
composition.

OPLS - DA
Orthogonal projection to latent structures – discriminant analysis (OPLS-DA) can
be used to characterize the genera that is discriminating the roasted coffee samples from
the green coffee samples. R package was used to perform OPLS-DA. OPLS-DA creates a
predictive model with dependent (X) and independent (Y) variables. It looks for hidden
(latent) variables that describes the class that we predetermined, in this case roasted and
green coffee (Table 3.2, 3.3).

6
fCOF03

4
2

fCOF04

0
-4

fCOF02

-2

-2

0

2

fCOF01

4

fCOF05

fCOF06

-4
-6
Figure 3.3: Plot of OPLS-DA analysis showing separation between green and roasted
coffee samples.
The predictive power (Q2) of the created model is 0.528 which is moderate and the
amount of variation (R2Y) explained by the model is 0.998. R2Y of 0.998 signifies that
most of the variation among samples was captured by the model.
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Table 3.2: Top genera discriminating roasted coffee samples
Top Discriminating Genera
(Roasted Coffee)
Escherichia/Shigella
Lactobacillus
Clostridium IV
Roseburia
Clostridium XI
Anaerostipes
Table 3.3: Top genera discriminating green coffee samples.
Top Discriminating Genera
(Green Coffee)
Providencia
Enterobacter
Bacteroides
Collinsella
Phascolarctobacterium
Erysipelotrichaceae IS

Alpha diversity
As described before, alpha diversity was calculated for each sample using
different indices such as Simpson’s D, Simpson’s E and Shannon’s H. Diversity increases
as Simpson’s D and Simpson’s E approaches 1, whereas, with Shannon’s H index the
diversity increases as the number calculated approaches infinity. The diversity numbers
indicate a moderately high alpha diversity (within sample species diversity) for each
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sample of the coffee project (Table 3.4). A higher within sample diversity depending the
type of species may confer health benefits to the organism.
Table 3.4: Summary of alpha diversity indices of fCOF samples.
V4
Sample ID Simpson’s D
fCOF03
0.102
fCOF04
0.075
fCOF06
0.095
fCOF01
0.094
fCOF02
0.096
fCOF05
0.091

Shannon’s H
3.942
4.210
3.946
3.899
4.000
3.976

Salami project results
Amplification and purification
Amplified and purified salami samples of PCR reaction were visualized after agarose gel
electrophoresis to check the presence and quality of the amplified DNA.
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Figure 3.4: Gel electrophoresis of 16S rRNA variable regions 1 and 2 of processed
salami samples.
The image confirms the presence and amplification of V1 and V2 regions of 16S rRNA
gene of representative samples after purification of amplicons from microbial population
derived from simulated digestion of salami with prebiotics.

High-throughput sequencing
After the amplification and purification of the desired regions of 16S RNA gene,
amplicons were sequenced on Ion Torrent PGM machine. The number of sequenced
reads for each sample obtained is depicted in Table 3.5. V4 regions yielded more
sequences than V1V2 region due to the technical difficulty involved in amplifying V1V2
region, which is longer in length (400 bp) compared to V4 (350 bp).
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Table 3.5: High-throughput sequencing reads of salami samples.
Sample content

Sample ID

Raw reads
for V1V2

Raw reads
for V4

Salami control
Fermentation fluid blank
Salami + Lactobacillus rhamnosus +
inulin
Salami + Lactobacillus rhamnosus +
fibergum
Salami + Lactobacillus rhamnosus +
citric fiber
Salami + Lactobacillus rhamnosus +
citric fiber + herbal extract

SC
FF
S + HW + IN

7035
4333
3365

22865
18132
22108

S + HW + FG 4928

19599

S + HW + CF 2702

19822

S + HW + CF 2316
+HE

22381

Relative genus level abundance
Relative genus abundance was calculated using a custom Microsoft Excel
template. It uses the results of Qiime analysis as the input; rarefied OTU table matrix.
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E
+C
F+
H
S+
HW

+C
F
S+
HW

+F
G
S+
HW

+I
N
S+
HW

FF

SC

0%

Sample content
Salami control
Fermentation fluid blank
Salami + Lactobacillus rhamnosus + inulin
Salami + Lactobacillus rhamnosus + fibergum
Salami + Lactobacillus rhamnosus + citric fiber
Salami + Lactobacillus rhamnosus + citric fiber + herbal extract

Sample ID
SC
FF
S + HW + IN
S + HW + FG
S + HW + CF
S + HW + CF +HE

Figure 3.5: Relative combined genus abundance graph of the salami project samples.
Bar graph of relative abundance of top 9 genera among samples of the salami project
after combining the genus abundance information from V1V2 and V4 regions.

PCoA of genus level dataset
PCoA was run in Qiime using a script for genus level analysis. As mentioned
before, it was done to visualize the dissimilarity between samples. Figure 3.4 and figure
3.5 represents the weighted phylogenetic distance UniFrac based plot of PCoA done on
the genus level inputs of V1V2 and V4 variable regions respectively. Figure 3.6
represents the weighted phylogenetic distance based UniFrac plot of combined genus
information of V1V2 and V4 regions.
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Figure 3.6: Weighted UniFrac plot of the combined region V1V2 and V4 data
PC1 represents the dimension where the most variability was found between samples and
PC2 is the second most varied dimension. Plots show a separation between samples
containing inulin fiber, control samples and samples containing fiber gum, fiber and fiber
with herbal extract. There is a grouping of three samples including fiber gum, citrus fiber
and citrus fiber with herbal extract maybe because those prebiotics are similar in
nutritional content.

Alpha diversity
As previously described, alpha diversity was calculated for each sample using
different indices such as Simpson’s D, Simpson’s E and Shannon’s H. Diversity increases
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as Simpson’s D and Simpson’s E approaches 0. However, with Shannon’s H index, the
diversity increases as the number calculated approaches infinity. As demonstrated in table
3.6 and table 3.7, the diversity numbers indicate low alpha diversity for each sample and
the numbers appear mostly consistent for both V1V2 and V4 abundance regions which
correspond to the same genera.
Table 3.6: Alpha diversity indices of fSAL samples - V1V2 region
Sample
HW + CF
FF
HW + IN
HW + CF + HE
SC
HW + FG

V1V2
Sample content
Salami +citric fiber
Fermentation fluid
Salami + inulin
Salami + citric fiber + herbal extract
Salami control
Salami + fibergum

Simpson’s D
0.010
0.007
0.015
0.007
0.012
0.006

Shannon’s H
6.022
5.860
5.620
6.021
5.733
6.087

Table 3.7: Alpha diversity indices of fSAL samples - V4 region
V4
Sample
HW + CF
FF
HW + IN
HW + CF + HE
SC
HW + FG

Sample content
Salami +citric fiber
Fermentation fluid
Salami + inulin
Salami + citric fiber + herbal extract
Salami control
Salami + fibergum

32

Simpson’s D
0.012
0.011
0.011
0.015
0.020
0.011

Shannon’s H
5.817
5.820
5.838
5.525
5.546
5.807

4. Discussion
This study aimed at characterizing the difference in gut microbiota composition in
the presence of distinct fermentable nutrients. We tested the capacity of fermentable
nutrients in roasted coffee, green coffee, salami mixed with various prebiotics and one
probiotic species to cause a change in the composition of microbiome in samples
obtained from gastrointestinal tract of three different people. By simulating the digestive
tract ex- vivo, we showed that it is possible to modulate the microbiome composition
with changing nutrition. Our study showed that there is a difference in abundance of
Escherichia, Shigella and Bifidobacterium, which were the top 3 most abundant genera
found in the most samples. Some strains of Escherichia and Shigella are known to cause
diarrhea in humans. So, reducing the abundance of Escherichia and Shigella may prove
to be therapeutic. Our study indicates that there is a reduction in the abundance of these
bacteria among fecal samples mixed with green coffee relative to samples mixed with
roasted coffee (fig.3.1). Bifidobacterium, on the other hand is used as a probiotic and is
associated with decreasing the incidence of diarrhea, colorectal cancer, and necrotizing
enterocolitis (Callaghan et al.,2016). Bifidobacterium is among the top 2 abundant
organisms in the coffee samples and the levels seem to be consistent across green coffee
and roasted coffee samples. Thus, coffee consumption can promote the abundance of this
genus in the human gut.
The top 2 most abundant genera among the salami samples include Bacteroides
and Bifidobacterium. As previously mentioned Bifidobacterium can be mostly therapeutic
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to humans. In the literature, Bacteroides in some cases can be pathogenic. This may or may not
be concerning to human health as our analysis describes relative abundance of the bacteria and
not the absolute abundance. PCoA analysis of both coffee project and salami fermentation
samples demonstrate a difference in respect to composition. Among the salami samples, there
was a clear separation between the control sample and the samples with fiber. Sample with inulin
was also separated from both the control and fiber infused samples. This may be because the
composition of inulin is different than other fiber samples.
The difference in microbial composition among samples may be explained by the
addition of prebiotics and probiotics to the fermentation process, as they could have altered the
dynamics of the microbiota in the gut. These components could have provided the necessary
environment and nutrients for the growth of a certain populations of bacteria over others, thus
altering the gut microbial interdependent network. This alteration is likely mediated by
microbially derived metabolites. However, we have not conducted a metabolite analysis with the
samples of this project.
Knowing that the specific nutrients tested can alter a simulated gut environment, the next
step is to look at the biological significance of such an effect. Not much is known about how the
diversity and abundance of some of the bacteria identified in the samples studied affect the
health of the host. Our study shows that including dietary fiber in salami undergoing
fermentation and the antioxidant capacity of coffee processed differently can influence the
microbiota community structure when ingested. Thus, consistent with the previous studies
showing diet can change the gut microbiome. However, it still needs to be seen to what extent
this can be used for therapeutic means in humans, and we still need to identify the specific
organisms that modulate the gut environment to benefit the human host.
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